TY - JOUR
T1 - Mechanism of cell adaptation
T2 - When and how do cancer cells develop chemoresistance?
AU - Fodale, Valentina
AU - Pierobon, Mariaelena
AU - Liotta, Lance
AU - Petricoin, Emanuel
PY - 2011/3
Y1 - 2011/3
N2 - Chemotherapy treatments are considered essential tools to defeat cancer progression and dissemination to improve patients' quality of life and survival. Although most malignancies initially respond to chemotherapeutic treatments, after an unpredictable period, tumor cells develop mechanisms of resistance to the treatment. Different cell compartments are involved in the mechanism of chemoresistance, and multiple mechanisms can be activated by single cells at different times of the cancer progression. Alteration of drug metabolism, derangement of intracellular pathways' signaling, cross-talk between different membrane receptors, and modification of apoptotic signaling and interference with cell replication are all mechanisms that the cell uses to overcome the effect of pharmacological compounds.In this review, we describe different adaptation, mostly at the level of the proteome, which cancer cells use to develop resistance to cancer treatment.
AB - Chemotherapy treatments are considered essential tools to defeat cancer progression and dissemination to improve patients' quality of life and survival. Although most malignancies initially respond to chemotherapeutic treatments, after an unpredictable period, tumor cells develop mechanisms of resistance to the treatment. Different cell compartments are involved in the mechanism of chemoresistance, and multiple mechanisms can be activated by single cells at different times of the cancer progression. Alteration of drug metabolism, derangement of intracellular pathways' signaling, cross-talk between different membrane receptors, and modification of apoptotic signaling and interference with cell replication are all mechanisms that the cell uses to overcome the effect of pharmacological compounds.In this review, we describe different adaptation, mostly at the level of the proteome, which cancer cells use to develop resistance to cancer treatment.
KW - Proteomics
KW - drug metabolism
KW - intracellular signaling
UR - http://www.scopus.com/inward/record.url?scp=79954524112&partnerID=8YFLogxK
U2 - 10.1097/PPO.0b013e318212dd3d
DO - 10.1097/PPO.0b013e318212dd3d
M3 - Review article
C2 - 21427552
AN - SCOPUS:79954524112
SN - 1528-9117
VL - 17
SP - 89
EP - 95
JO - Cancer Journal
JF - Cancer Journal
IS - 2
ER -